PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test:: Results of a preliminary study and future implications

被引:15
作者
Bianchi, A
Moret, F
Desrues, JM
Champenois, T
Dervaux, Y
Desvouas, O
Oursin, A
Quinzat, D
Dachez, R
Bathelier, C
Ronsin, C
机构
[1] LCL, Serv Biol Mol, F-94208 Ivry, France
[2] Conseil Gen, Lab Dept Seine St Denis, Bondy, France
[3] Roche Diagnost, Meylan, France
[4] Cytyc France SARL, Villepinte, France
[5] Lab Claude Levy, Paris, France
关键词
D O I
10.1128/JCM.40.5.1749-1754.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The commercial COBAS Amplicor CT/NG test (Roche Diagnostic Systems, Meylan, France) is a sensitive and specific method for detection of Chlamydia trachomatis infections. This test currently consists of using a nucleic acid amplification method to detect C. trachomatis in first-void urine specimens and in endocervical swabs collected in 2-sucrose-phosphate (2SP) transport medium. We conducted a prospective study to determine whether the automated COBAS Amplicor CT/NG test can detect C. trachomatis in cervical specimens collected in PreservCyt transport medium (ThinPrep Pap Test; Cytyc Corporation, Boxborough, Mass.). PreservCyt medium is used to preserve cervical samples before the preparation of ThinPrep slides. We collected 1,000 cervical specimens from young women (age range, 15 to 25 years) during routine Pap smear tests. Only specimens with normal cytology and in which the gynecologist found no clinical evidence of urogenital infections were selected. The samples were stored in PreservCyt transport medium at 15 to 20degreesC. C. trachomatis was detected in 22 of the 1,000 cervical specimens that had been stored in PreservCyt. To confirm the positive samples, the test was repeated on new endocervical swab specimens collected in 2SP transport medium. Only 9 of the 22 positive patients agreed to undergo this control, but all 9 retested positive. To evaluate the influence of storage conditions on the sensitivity of the C. trachomatis PCR test, all of the positive samples were stored at 15 to 20degreesC in PreservCyt transport medium and were retested every 2 weeks for 6 weeks. C. trachomatis was successfully amplified from all 22 specimens for the whole 6-week period. The prevalence of C. trachomatis infection was 2.2% in our study population. These results demonstrate that PreservCyt transport medium is a suitable transport medium for detection of C. trachomatis by the COBAS Amplicor CT/NG test. The ThinPrep Pap Test may enable gynecologists to monitor for both cervical lesions and C. trachomatis infections with a single endocervical specimen.
引用
收藏
页码:1749 / 1754
页数:6
相关论文
共 51 条
[41]   Detection of Chlamydia trachomatis in urine samples by nucleic acid tests: Comparison with culture and enzyme immunoassay of genital swab specimens [J].
Schepetiuk, S ;
Kok, T ;
Martin, L ;
Waddell, R ;
Higgins, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3355-3357
[42]   Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection [J].
Scholes, D ;
Stergachis, A ;
Heidrich, FE ;
Andrilla, H ;
Holmes, KK ;
Stamm, WE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1362-1366
[43]  
Sherman ME, 1998, MODERN PATHOL, V11, P837
[44]  
Sherman ME, 1997, CANCER CYTOPATHOL, V81, P89
[45]   Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay [J].
Toye, B ;
Peeling, RW ;
Jessamine, P ;
Claman, P ;
Gemmill, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1396-1400
[46]   Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis [J].
Van der Pol, B ;
Quinn, TC ;
Gaydos, CA ;
Crotchfelt, K ;
Schachter, J ;
Moncada, J ;
Jungkind, D ;
Martin, DH ;
Turner, B ;
Peyton, C ;
Jones, RB .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1105-1112
[47]   Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens [J].
Vincelette, J ;
Schirm, J ;
Bogard, M ;
Bourgault, AM ;
Luijt, DS ;
Bianchi, A ;
Vader, PCV ;
Butcher, A ;
Rosenstraus, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (01) :74-80
[48]  
WARSZAWSKI J, 1997, B E H, V15, P65
[49]  
*WHO, 2000, IN HIV AIDS SEX TRAN
[50]   ADVANCES IN NUCLEIC ACID-BASED DETECTION METHODS [J].
WOLCOTT, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1992, 5 (04) :370-386